ENARA BIO
HQ - Oxford
Summary
Ervaxx is illuminating the immune interface to develop new cancer therapies.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 24 M
Avg. Deal Size£ 24 M
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite
